The experiments involving stimulation and inhibition of the expression of β3-AR have shown, for the first time, that long-term stimulation of β3-AR for 1 month can ameliorate liver lipid accumulation, liver steatosis and inflammation associated with NAFLD. The gene discussed is ADRB3; the disease is metabolic dysfunction-associated steatotic liver disease.